Paralysis of accommodation

Accommodation paralysis, or cycloplegia, is a condition in which the ciliary muscle loses its ability to contract, causing the eye to lose focus on close objects and impairing reading and near work. It is most often caused by medications with anticholinergic effects, and less commonly by damage to the parasympathetic innervation or inflammatory and traumatic causes. Unlike accommodation spasm, with paralysis, there is no response to stimuli, and the range of accommodation is reduced to zero or close to zero. In everyday life, the patient notices a sudden "switching off" of near vision and pupil dilation, with decreased tolerance to bright light. [1]

Understanding the mechanism is important for treatment decisions, as drug-induced cycloplegia is usually reversible after drug withdrawal, whereas neurogenic forms require identification and treatment of the underlying cause. During an ophthalmologist consultation, medication history, pupillary response testing, and objective accommodation tests are key. Standardized approaches to measuring accommodation volume and assessing myopia or hyperopia help differentiate primary refractive error from true loss of ciliary muscle function. This allows for timely symptomatic correction and monitoring. [2]

Code according to ICD-10 and ICD-11

In the International Classification of Diseases, Tenth Revision, accommodation paralysis is listed under "Refractive and Accommodation Disorders" with the base code H52.5. For further clarification, the subheading H52.52 "Accommodation Paresis" is used, specifying the side where necessary. These codes are used for drug-induced cycloplegia and neurogenic causes, recording the impairment of the focusing mechanism. It is helpful to include a related cause in the documentation, such as cycloplegic use or concomitant neuropathy. [3]

The International Classification of Visual Impairments, Eleventh Revision, includes the category 9D01 "Accommodation Disorders," and the specific condition "Accommodation Paresis" is coded 9D01.1. The electronic structure of ICD-11 allows for the addition of etiologic modifiers, facilitating statistical accounting of drug-induced and neurogenic forms. For reporting visual disorders, it is important to select the most accurate code from the 9D01 family. This simplifies patient routing and insurance decisions. [4]

Table 1. Correspondence of ICD codes to accommodation paralysis

Classifier	Base unit	Specific code	Comment
ICD-10	H52 "Refractive and accommodation disorders"	H52.52 "Paresis of accommodation"	Detailing by eye is possible
ICD-11	9D01 "Accommodation disorders"	9D01.1 "Paresis of accommodation"	It is permissible to indicate the reason
[5]

Epidemiology

Accommodation paralysis is less common than accommodation spasm and presbyopia and is considered a rare disorder, so precise population prevalence rates are unavailable. Most observations involve drug-induced cases in ophthalmologists' offices using cycloplegics for diagnosis and treatment. Neurogenic forms have been described as isolated case series and clinical cases. According to clinical guidelines, the condition is considered rare in general practice. [6]

The proportion of drug-induced causes is higher in children and young adults due to the frequent use of cycloplegics in objective refraction assessment and the treatment of inflammatory conditions. In the elderly group, the relative contribution of neurogenic and vascular factors increases, but the absolute numbers remain low. Gender differences are minimal and are determined by etiology. For occupational health and safety services, clinical significance is primarily associated with temporary disability due to pharmacological cycloplegia. [7]

Table 2. Epidemiological landmarks

Indicator	Trend	Note
General prevalence	low	rare condition, no exact percentages
Age	children and young adults more often with the dosage form	the use of cycloplegics in diagnostics
Etiology	medicinal predominates	neurogenic forms are rare
Floor	there are no significant differences	depends on the reason
[8]

Reasons

Cycloplegic drugs are the predominant cause: atropine, cyclopentolate, and tropicamide block muscarinic receptors, relax the ciliary muscle, and temporarily inhibit accommodation. The duration of effect depends on the drug and dose, with atropine having the longest duration. Even with proper use, a prolonged effect is possible in sensitive patients. [9]

Neurogenic causes are associated with damage to the parasympathetic pathways and short ciliary nerves: neuritis, midbrain diseases, head trauma, ischemic events, oculomotor nerve palsy, botulism, and diphtheria. In these cases, loss of accommodation is often accompanied by changes in pupillary response and other neurological symptoms. Prompt neuroimaging and consultation with a neurologist are indicated if a central process is suspected. [10]

Inflammatory and traumatic causes include uveitis, anterior segment injuries, and surgeries that affect the ciliary girdle and arcus muscle mechanisms. Toxic effects also contribute to accommodation paralysis. In each case, a history of events prior to onset helps establish a causal relationship. [11]

Table 3. Common causes of accommodation paralysis

Group	Examples	Peculiarities
Medicinal	atropine, cyclopentolate, tropicamide	temporary cycloplegia, dose-dependent
Neurogenic	midbrain lesions, paralysis of the third nerve	often accompanied by pupillary disturbances
Inflammatory and traumatic	uveitis, trauma, anterior segment surgery	mechanical or functional shutdown
[12]

Risk factors

The risk of drug-induced cycloplegia is increased by high sensitivity to anticholinergics, the use of long-acting medications, and multiple instillations at short intervals. Additional factors include younger age and a light-colored iris, which affects pharmacokinetics in the anterior chamber. A proper instillation protocol reduces the likelihood of excessive duration of effect. [13]

Neurogenic forms of the disease are associated with traumatic brain injury, central nervous system infections, vascular events, and demyelinating processes. In the presence of such factors, sudden bilateral deterioration of near vision with impaired pupillary responses is a cause for concern. The presence of systemic neurological symptoms requires further diagnostic testing. [14]

Inflammatory diseases of the anterior segment and recent ocular surgery increase the risk of temporary ciliary muscle inactivity. Transient accommodation dysfunctions have been reported when working with solvents and toxic substances, which is important to consider in occupational safety. Prevention includes personal protective equipment and exposure control. [15]

Pathogenesis

Normal accommodation is achieved by contraction of the ciliary muscle and relaxation of the zonules, which thickens the lens and increases its optical power. In accommodation paralysis, muscarinic transmission is blocked or disrupted, the muscle remains relaxed, and the lens is fixed in a "flat" position. As a result, near vision is sharply impaired, while distance vision is usually preserved. This distinguishes the condition from spasm, where the opposite configuration is observed. [16]

Pharmacological cycloplegia is achieved through competitive blockade of M-acetylcholine receptors, with the strength and duration of the effect varying for atropine, cyclopentolate, and tropicamide. Experiments and clinical studies have shown that atropine produces the most pronounced and prolonged cycloplegia, which is useful for diagnostics but may be undesirable in everyday life. Drug selection should take into account the patient's goals and safety profile. [17]

In central and peripheral neurogenic causes, the arc from the Edinger-Westphal nucleus to the short ciliary nerves is disrupted. This leads to a combination of accommodative and pupillary deficits, sometimes with concomitant eye movement disorders. The clinical phenotype helps localize the level of damage and determine the priority of examinations. [18]

Symptoms

The main symptom is a sudden or subacute inability to read at a normal distance due to severe blurring of near images. Pupil dilation and decreased tolerance to bright light are often combined, which is particularly noticeable outdoors and when working with screens. Children and adolescents may experience a sharp decline in academic performance on near tasks. Parents often attribute this to "sudden farsightedness." [19]

In the neurogenic form, diplopia, ptosis, and changes in pupillary light and convergence responses are added, indicating involvement of the oculomotor nerve or central structures. These signs increase the urgency of examination. In the drug-induced form, symptoms usually regress as the drug concentration in the ocular tissue decreases. It is important to warn the patient about the temporary nature of the symptoms. [20]

Classification, forms and stages

Based on etiology, drug-induced, neurogenic, inflammatory, and traumatic forms are distinguished, with drug-induced being the most common. Depending on the affected side, unilateral and bilateral forms are distinguished; with neurogenic causes, both eyes are often involved. Based on the course, an acute onset is described with cycloplegic instillation, while a subacute or gradual onset is observed with inflammatory and neurogenic processes. This division helps plan the examination. [21]

Table 4. Practical classification

Base	Categories	Clinical value
Etiology	medicinal, neurogenic, inflammatory, traumatic	guides diagnosis and treatment
Side	one-sided, two-sided	indirect sign of the central process
Flow	acute, subacute, gradual	determines the urgency of the examination
[22]

Complications and consequences

The main functional effect is a significant limitation of near work, reading, studying, and driving when viewing instrument panels, which reduces quality of life and productivity. With the drug form, temporary disability is predictable based on the duration of action of the drug used. This should be taken into account when planning procedures. [23]

In cases of neurogenic etiology, persistent impairment is possible without treatment of the underlying cause, including chronic accommodation deficit and pupillary abnormalities. In such cases, the risk of asthenopia and secondary complaints increases. Early diagnosis and interdisciplinary management improve outcomes. [24]

When to see a doctor

Consult an ophthalmologist immediately if, while using pupil dilation drops, you experience loss of near vision and symptoms persist beyond the expected time period prescribed by your doctor. A specialist will assess the severity of cycloplegia and prescribe temporary measures to reduce discomfort and prevent complications. Information about the medication and instillation times will significantly expedite treatment. [25]

If near vision impairment occurs suddenly without instillation and is accompanied by double vision, ptosis, severe headache, or pupillary changes, this is a reason for urgent evaluation for a neurogenic cause. The doctor will consider neuroimaging and a consultation with a neurologist. Delay in seeking medical attention may worsen the prognosis. [26]

Diagnostics

The first step is a detailed medical history, focusing on recent cycloplegic instillations, systemic medications, and trauma, as well as testing pupillary responses and convergence. Visual acuity at distance and near is assessed, and objective refractometry is performed before and after pharmacological intervention, if necessary. This helps distinguish refractive error from true loss of accommodation. [27]

Accommodation volume is then measured using push-up and push-down methods, near-point clear vision is tested, and complaints are recorded while reading standard charts. In complex cases, electrophysiological and modern quantitative methods are used, and the impact of cycloplegia on binocular vision is assessed. Proper standardization of conditions improves the reproducibility of results. [28]

If the neurogenic form is suspected, a neurological examination and neuroimaging are indicated to rule out midbrain and oculomotor nerve damage. Laboratory tests are also considered if infectious or toxic causes are suspected. The extent of the examination is determined by clinical clues. [29]

Table 5. Diagnostic methods and tasks

Method	What does it show?	When to apply
Medication history and pupillary examination	confirmation of drug-induced cycloplegia	with recent instillations
Measuring the volume of accommodation	quantitative assessment of the deficit	in case of any suspicion
Objective refraction	impact on distant and near vision	before and after exposure
Neuroimaging	search for a central cause	with neurological signs
[30]

Differential diagnosis

It is important to distinguish accommodation paralysis from presbyopia, where the decline in function is caused by age-related lens rigidity and progresses gradually. In presbyopia, pupillary responses are preserved, and a response to weak accommodative stimuli is partially possible. Unlike drug-induced cycloplegia, symptoms are not associated with instillations and do not regress on their own. [31]

Another common mimic is accommodation spasm, in which distance blurring and pseudo-myopia predominate, and tests show excessive tone. Accurate methods for assessing the volume and direction of the response resolve the distinction. In questionable situations, observation against a background of mild cycloplegics with dynamic monitoring is helpful. [32]

Table 6. Differences between states

Sign	Paralysis of accommodation	Accommodation spasm	Presbyopia
Start	sudden or subacute	subacute	gradual
Vision	sharply reduced near	suffers in the distance	suffers nearby, age dynamics
Pupil	often expanded	usually without any special features	without any peculiarities
Connection with drops	often yes	No	No
[33]

Treatment

The first principle is to eliminate the cause. With a medicinal form, it is sufficient to stop instillations and wait for the drug concentration in the tissues to decrease, after informing the patient of the typical duration of effect for the chosen medication. Atropine lasts longer, while cyclopentolate and tropicamide last shorter, which is taken into account when planning. It is important to avoid repeat instillations on your own. [34]

To facilitate near work during cycloplegia, temporary plus reading aids are prescribed for reading with glasses or by increasing the distance and font size. This quickly reduces asthenopia and allows for continued study and work. A practical recommendation is to use electronic devices with interface scaling and brightness levels comfortable for dilated pupils. [35]

In cases of neurogenic etiology, therapy is aimed at the underlying disorder: anti-inflammatory treatment for neuritis, antibacterial or antiviral therapy for infections, and neurosurgical approaches for space-occupying lesions. As the underlying cause stabilizes, partial restoration of accommodation is possible, which is monitored by quantitative tests. Interdisciplinary management improves the prognosis. [36]

Low-concentration pilocarpine drops can temporarily improve near vision in certain situations due to their miotic and accommodative effects, as demonstrated in recent clinical studies in patients with loss of accommodation and presbyopia. The decision is individualized, taking into account the risk of spasms, headaches, and decreased distance vision. Clinical trials specifically for accommodation paralysis are needed. [37]

Photophobia can be reduced by using sun protection: glasses with filters, a visor, and screen brightness controls. This is especially important in cases of severe drug-induced mydriasis. Simple measures significantly improve comfort until the effect subsides completely. Patients are advised in advance that photosensitivity is temporary. [38]

Temporary refractive solutions are acceptable: plus supplements in reading glasses, clip-ons for near work, and adjustments to working distances. Permanent prescription changes are undesirable until the condition resolves, as this increases the risk of overcorrection after function is restored. A follow-up examination is scheduled after the expected effect of the medication has worn off. [39]

In cases of long-term neurogenic dysfunction with significant occupational impact, specialized optical solutions for near tasks are discussed, including individualized supplementation and workplace modifications. Visual endurance training is ineffective until the accommodation mechanism is restored, so the primary focus is on compensation and safety. This reduces asthenopic complaints. [40]

For ophthalmologic inflammatory conditions where cycloplegics were used as indicated, a treatment withdrawal plan is discussed with the physician: gradual discontinuation, transition to shorter-acting medications, and control of pain and iris sphincter spasm. The goal is a balance between therapeutic benefit and functional limitations in near vision. Detailed instructions reduce patient anxiety. [41]

The targeted use of low-concentration pilocarpine and other approaches to improve near vision is being studied in research, but use in accommodative paralysis should be based on clinical feasibility and safety. Until specific protocols are developed, conservative measures and personalized selection are preferred. Monitoring of accommodative volume is mandatory. [42]

Finally, educational measures: the patient is informed in advance about the expected duration of the effect, safety rules for driving and operating machinery, and signs requiring a follow-up visit. Written reminders and instructions reduce the number of unscheduled visits and increase satisfaction with treatment. This is especially important in pediatric practice. [43]

Table 7. Management tools

Approach	Target	Evidence base	Comment
Stopping or waiting for the drug to wear off	eliminate the cause	pharmacology and clinic	basic tactics
Temporary plus supplement	make working nearby easier	clinical guidelines	do not change the permanent recipe
Low concentration pilocarpine	short-term improvement in near vision	modern research	individual risk profile
Treatment of the cause in the neurogenic form	restoration of function	data on major diseases	interdisciplinary approach
[44]

Prevention

When cycloplegia is planned, the ophthalmologist should inform the patient of the duration of action of the chosen medication and time restrictions for work and school. It is recommended to schedule procedures during times free from intense near-eye activity and to prepare compensatory measures in advance. This will minimize stress and complaints. [45]

In the clinic, it is useful to select the minimum effective concentration and frequency of instillations, especially in children and highly sensitive individuals. Adherence to protocols reduces the risk of excessive cycloplegia duration. Personnel training and standardization of processes improve safety. [46]

Prevention of neurogenic forms involves controlling risk factors for damage to the central nervous system and oculomotor nerves, and promptly treating infections and injuries. Early treatment for alarming symptoms increases the chance of reversibility. Patients with neurological diseases are given clear recommendations regarding when to seek examination. [47]

Forecast

Drug-induced cycloplegia is almost always reversible and resolves after the drug is withdrawn, although the time frame varies depending on the agent. With proper information and temporary optical compensation, the impact on quality of life is minimal and short-lived. Follow-up examinations are only necessary if the condition is unusually prolonged. [48]

The prognosis for neurogenic forms is determined by the cause and the speed of its treatment: in inflammatory and infectious processes, partial or complete recovery is possible, while in structural lesions of the central nervous system, the deficit may persist. Regular quantitative assessment of the volume of accommodation helps monitor progress. An interdisciplinary approach increases the chances of success. [49]

FAQ

Is this dangerous for the eyes?
Drug-induced accommodation paralysis itself does not damage the ocular structure and resolves as the drug's effects wear off. It's important to know safety precautions and temporarily use optical compensation. If neurological symptoms develop, prompt examination is necessary. [50]

How long does "poor near vision" last after using the drops?
It depends on the medication: atropine lasts longer, while cyclopentolate and tropicamide last shorter. Your doctor will advise you on the specific duration before the procedure. If the effect lasts significantly longer than expected, seek a follow-up examination. [51]

Is it possible to speed up recovery?
There is no specific antidote for topical cycloplegics, so the key is time, protection from bright light, and temporary positive supplementation. In some cases, an ophthalmologist may consider low-concentration pilocarpine for short-term improvement of near vision, taking into account the risks. [52]

How can you tell if the cause is drug-related?
The absence of recent instillations, the presence of ptosis, diplopia, significant pupil changes, and other neurological signs suggest a neurogenic cause. In this situation, a more comprehensive diagnosis is required. [53]